
Loading, please wait...

Loading, please wait...

The India medical device industry is currently undergoing a massive transformation. According to a recent report by Rubix Industry Insights, the sector will likely reach a valuation of USD 50.1 billion by 2030. This growth represents an impressive compound annual growth rate (CAGR) of 26.9 per cent from its 2025 valuation of USD 15.2 billion. Consequently, India remains a pivotal player, currently ranking as the fourth-largest market in Asia and holding a spot among the top 20 globally.
Several factors are driving this rapid expansion across the country. Primarily, rising income levels and expanding health insurance penetration are boosting demand. Furthermore, the growth of medical tourism and increasing healthcare infrastructure provide a solid foundation for both affordable and advanced solutions. However, the sector still faces a significant trade imbalance that requires strategic intervention. Such growth demands a shift toward domestic self-reliance.
Currently, the industry remains largely import-dependent. Approximately 70-80% of domestic demand is met through imports, especially for technologically advanced devices. For instance, electro-medical equipment accounts for nearly 60% of imports. In contrast, India shows immense strength in consumables, which make up 47% of its exports. Therefore, the government aims to raise India's global market share from 1.6% to approximately 12% in the coming years.
Government initiatives play a critical role in strengthening the domestic manufacturing base. Programs like the National Medical Devices Policy (NMDP) and the Production-Linked Incentive (PLI) Scheme provide essential support. Additionally, the MedTech Mitra and the Scheme for Promotion of Medical Devices Parks are fostering innovation. These policies aim to reduce reliance on imports and improve price competitiveness for local manufacturers. This ecosystem encourages high-tech development.
Geographically, four states are leading this industrial evolution. Uttar Pradesh, Maharashtra, Haryana, and Karnataka are strengthening the ecosystem by providing shared infrastructure. Moreover, these states offer skilled manpower and robust supplier networks. This environment specifically helps small and mid-sized manufacturers scale their production efficiently. Consequently, private equity and venture capital funding have also seen a massive 2.5-fold increase in average deal size since 2022.
Q1: What is the expected market size of the Indian medical device sector by 2030?
The industry is projected to reach USD 50.1 billion by 2030, growing at a CAGR of 26.9 per cent from USD 15.2 billion in 2025.
Q2: Which government schemes are supporting the medical device industry in India?
Key initiatives include the National Medical Devices Policy (NMDP), the Production-Linked Incentive (PLI) Scheme, and MedTech Mitra.
Q3: Which states are major hubs for medical device manufacturing in India?
Uttar Pradesh, Maharashtra, Haryana, and Karnataka are the leading states contributing to the industry's infrastructure and skilled workforce.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


India's medical device industry is projected to reach $50.1 billion by 2030, supported by government initiatives like NMDP and PLI schemes for manufacturing...
8 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today